Form 8-K - Current report:
SEC Accession No. 0000950170-25-108441
Filing Date
2025-08-14
Accepted
2025-08-14 08:00:33
Documents
10
Period of Report
2025-08-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20250813.htm   iXBRL 8-K 43121
  Complete submission text file 0000950170-25-108441.txt   145451

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250813.xsd EX-101.SCH 23938
12 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250813_htm.xml XML 4526
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 251214434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)